Anxiolytic Effect of a Novel 5-HT3 Receptor Antagonist (4-Phenylpiperazin-1-yl)(Quinoxalin-2-yl) Methanone (4a) in a Battery of Behavioral Models for Anxiety in Mice

No Thumbnail Available

Date

2013

Journal Title

Journal ISSN

Volume Title

Publisher

The Pharma Innovation

Abstract

The serotonergic system of brain is well understood to play a crucial role in emotional processing in human and animals. 5-HT3 receptor, the ion channel type of receptor is involved in mood, anxiety, depression, learning and memory. Objective of the present work was to investigate the anxiolytic potential of a novel 5-HT3 receptor antagonist (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a) in mice. Different behavioral test paradigms for anxiety like elevated plus maze, open field test, light-dark model and hole board test were used for assessing the effect. Diazepam 2 mg/kg i.p. served as a reference standard. From the results it was found that 4a dose dependently at 2 and 4 mg/kg i.p. attenuated the behavioral alterations in the anxiety models in mice. The exact mechanism of 5- HT3 receptor antagonist for anxiolytic potential is still ill understood. Our further studies will deal with mechanisms at molecular levels for anxiolytic potential of 4a

Description

Keywords

Pharmacy, 5-HT3 Receptor, Anxiety, Elevated plus maze (EPM), Open field test (OFT)

Citation

Endorsement

Review

Supplemented By

Referenced By